PMLive20 小时
Sanofi expands immunology pipeline by acquiring Dren’s bispecific for $600m upfront
Sanofi has announced that it will be broadening its immunology pipeline by acquiring Dren Bio’s phase 1 CD20-directed ...
PMLive20 小时
AstraZeneca’s Imfinzi granted EC approval for limited-stage small cell lung cancer
AstraZeneca (AZ) has announced that its immunotherapy Imfinzi (durvalumab) has been approved by the European Commission (EC) ...
PMLive20 小时
Novartis shares positive phase 3 results for spinal muscular atrophy gene therapy
Novartis also shared results from the open-label phase 3b STRENGTH study of OAV101 IT in SMA patients aged two to less than 18 years who had discontinued treatment with nusinersen or risdiplam, which ...
PMLive20 小时
Harnessing AI and big data in clinical research
For example, developing a drug nowadays takes eight to ten years and costs over $2bn, yet less than 10% of clinical ...